Nutra Pharma Corporation , a biotechnology company that is developing treatments for Multiple Sclerosis , Human Immunodeficiency Virus , Adrenomyeloneuropathy and Pain, announced today that New , a marketing and distribution company, has placed and received their first order of the Company's all-natural, non-addictive pain reliever, Nyloxin.
http://it.tmcnet.com/news/2013/08/29/7374718.htm
http://it.tmcnet.com/news/2013/08/29/7374718.htm
No comments:
Post a Comment